Refine
Year of publication
Document Type
- Preprint (262)
- Article (188)
- Part of a Book (1)
- Working Paper (1)
Has Fulltext
- yes (452)
Is part of the Bibliography
- no (452)
Keywords
- LHC (9)
- Heavy Ion Experiments (6)
- ALICE experiment (4)
- Heavy Ions (4)
- Hadron-Hadron Scattering (3)
- Hadron-Hadron scattering (experiments) (3)
- Heavy-ion collision (3)
- pp collisions (3)
- ALICE (2)
- Beauty production (2)
- Charm physics (2)
- Heavy-ion collisions (2)
- Pb–Pb collisions (2)
- Single electrons (2)
- ALICE detector (1)
- Anti-nuclei (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charged-particle density (1)
- Comparison with QCD (1)
- Cryoelectron microscopy (1)
- Electron-pion identification (1)
- Elliptic flow (1)
- FDG-PET/CT (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- HACA (1)
- HBT (1)
- HNSCC (1)
- Hadron production (1)
- Head neck cancer (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Immunotherapy (1)
- Inclusive spectra (1)
- Induction therapy (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Jets (1)
- Mass spectrometry (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Monte Carlo (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Neural network (1)
- Nuclear modification factor (1)
- Particle correlations and fluctuations (1)
- Pb–Pb (1)
- Production Cross Section (1)
- Proton–proton (1)
- QCD (1)
- Quark gluon plasma (1)
- Rapidity Range (1)
- Relativistic heavy ion physics (1)
- Resolution Parameter (1)
- Ribosome (1)
- Single muons (1)
- Systematic Uncertainty (1)
- TR (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Trigger (1)
- Wide rapidity coverage (1)
- Xenon-based gas mixture (1)
- acute lymphoblastic leukemia (1)
- anti-GD2 immunotherapy (1)
- ch14.18/CHO (1)
- chimeric antigen receptor (CAR) (1)
- complement dependent cytotoxicity (1)
- dE/dx (1)
- flow cytometry (1)
- heavy ion experiments (1)
- immune monitoring (1)
- immunotherapy (1)
- long-term infusion (1)
- neuroblastoma (1)
- pain (1)
- quark gluon plasma (1)
- spectra (1)
- √sN N = 2.76 TeV (1)
Institute
Chimeric antigen receptor (CAR) T cell therapy is a potent new treatment option for relapsed or refractory hematologic malignancies. As the monitoring of CAR T cell kinetics can provide insights into the activity of the therapy, appropriate CAR T cell detection methods are essential. Here, we report on the comprehensive validation of a flow cytometric assay for peripheral blood CD19 CAR T cell detection. Further, a retrospective analysis (n = 30) of CAR T cell and B cell levels over time has been performed, and CAR T cell phenotypes have been characterized. Serial dilution experiments demonstrated precise and linear quantification down to 0.05% of T cells or 22 CAR T cell events. The calculated detection limit at 13 events was confirmed with CAR T cell negative control samples. Inter-method comparison with real-time PCR showed appreciable correlation. Stability testing revealed diminished CAR T cell values already one day after sample collection. While we found long-term CAR T cell detectability and B cell aplasia in most patients (12/17), some patients (5/17) experienced B cell recovery. In three of these patients the coexistence of CAR T cells and regenerating B cells was observed. Repeat CAR T cell infusions led to detectable but limited re-expansions. Comparison of CAR T cell subsets with their counterparts among all T cells showed a significantly higher percentage of effector memory T cells and a significantly lower percentage of naïve T cells and T EMRA cells among CAR T cells. In conclusion, flow cytometric CAR T cell detection is a reliable method to monitor CAR T cells if measurements start without delay and sufficient T cell counts are given.
Panel discussion
(2019)